Table 1.
General Clinical and Laboratory Parameter in Participants with and without MAFLD
| Variable | Controls | MAFLD | P |
|---|---|---|---|
| N | 176 | 176 | |
| Sex(M/F) | 88/88 | 88/88 | 1.000 |
| #Age(years) | 40(31−54) | 44(35−56) | 0.103 |
| #BMI(kg/m2) | 23(21−24) | 26(24−28) | <0.001 |
| #WC(cm) | 83(75−88) | 93(88−99) | <0.001 |
| *HC (cm) | 98.29±6.32 | 102.40±6.32 | <0.001 |
| #SBP (mmHg) | 120(109−133) | 132(121−142) | <0.001 |
| #DBP (mmHg) | 77(72−87) | 85(80−90) | <0.001 |
| #FBG(mmol/L) | 4.96(4.60−5.33) | 5.32(4.95−5.83) | <0.001 |
| #TG(mmol/L) | 1.03(0.76−1.39) | 1.07(1.21−2.14) | <0.001 |
| *TC (mmol/L) | 4.76±0.83 | 5.17±0.98 | <0.001 |
| #UA(μmol/L) | 332.40(271.45−377.87) | 342.40(299.60−409.70) | 0.006 |
| #Creatinine(μmol/L) | 68(57−81) | 66(57−77) | 0.126 |
| #ALT(U/L) | 15(12−20) | 22(16−35) | <0.001 |
| #AST(U/L) | 21(18−25) | 23(20−28) | <0.001 |
| #γ-GGT(mmol/L) | 18.50(14.30−24.07) | 26.80(20.40−40.90) | <0.001 |
| *LDL-C(mmol/L) | 2.94±0.63 | 3.30±0.74 | 0.231 |
| *HDL-C(mmol/L) | 1.36±0.25 | 1.24±0.27 | <0.001 |
| #WBC(×109/L) | 5.90(5.10−7.00) | 6.50(5.50−7.33) | 0.007 |
| #Metrnl(pg/mL) | 379.06(248.81−504.70) | 240.40(176.28−305.75) | <0.001 |
Notes: *Data normally distributed are shown as mean ± SD. Independent Sample t test was performed. #Data with skewed distribution are shown as median (25th−75th). Mann–Whitney U-test was performed.
Abbreviations: BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, Triglyceride; TC, Total cholesterol; UA, uric acid; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GGT, γ-gamma glutamyl transferase; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; WBC, white blood cell.